» Articles » PMID: 18801550

Rhesus Angiotensin Converting Enzyme 2 Supports Entry of Severe Acute Respiratory Syndrome Coronavirus in Chinese Macaques

Overview
Journal Virology
Specialty Microbiology
Date 2008 Sep 20
PMID 18801550
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Angiotensin converting enzyme 2 (ACE2) is the receptor that severe acute respiratory syndrome coronavirus (SARS-CoV) utilizes for target cell entry and, therefore, plays an important role in SARS pathogenesis. Since Chinese rhesus (rh) macaques do not usually develop SARS after SARS-CoV infection, it has been suggested that rh-ACE2 probably does not support viral entry efficiently. To determine the role of rh-ACE2 in early lung pathogenesis in vivo, we studied eleven Chinese rhesus monkeys experimentally infected with a pathogenic SARS-CoV(PUMC01) strain. Rh-ACE2 genes were amplified from all animals by reverse transcription polymerase chain reaction, and their function was studied in vitro using a pseudovirus entry assay. Many natural non-synonymous (NS) changes were found in rh-ACE2 genes. Compared to human (hu) ACE2, thirty-eight consensus NS changes were found in rh-ACE2. Since these changes do not interact with the receptor binding domain of SARS-CoV, rh-ACE2 in general is as effective as human homolog in supporting viral entry. Rh-ACE2, however, is more polymorphic than hu-ACE2. Additional sporadic NS substitutions in clone Rh11-7 reduced the level of rh-ACE2 protein expression and did not support viral entry effectively. Further mutagenesis analysis showed that a natural mutation Y217N dramatically alters ACE2 expression and entry efficiency. Moreover, introduction of the Y217N mutation into hu-ACE2 caused the down-regulation of expression and reduced viral entry efficiency. These results indicate that the Y217N mutation plays a role in modulating SARS-CoV infection. Our results provide insights for understanding the role of rh-ACE2 in SARS lung pathogenesis in a non-human primate model.

Citing Articles

Detached epithelial cell plugs from the upper respiratory tract favour distal lung injury in Golden Syrian hamsters (Mesocricetus auratus) when experimentally infected with the A.2 Brazilian SARS-CoV-2 strain.

Pelajo-Machado M, da Silva A, Rodrigues D, Paiva M, Muller R, da Costa L Mem Inst Oswaldo Cruz. 2024; 119:e240100.

PMID: 39442103 PMC: 11493349. DOI: 10.1590/0074-02760240100.


COVID-19 susceptibility: potential of polymorphisms.

Chaudhary M Egypt J Med Hum Genet. 2024; 21(1):54.

PMID: 38624559 PMC: 7502288. DOI: 10.1186/s43042-020-00099-9.


Experimental and clinical data analysis for identification of COVID-19 resistant ACE2 mutations.

Raghav P, Raghav A, Lathwal A, Saxena A, Mann Z, Sengar M Sci Rep. 2023; 13(1):2351.

PMID: 36759535 PMC: 9910265. DOI: 10.1038/s41598-022-20773-9.


Animal models and SARS-CoV-2-induced pulmonary and neurological injuries.

Pinto M, da Silva A, Rodrigues D, Muller R, de Vasconcelos G, Neves P Mem Inst Oswaldo Cruz. 2023; 117:e220239.

PMID: 36700583 PMC: 9870265. DOI: 10.1590/0074-02760220239.


Mitochondrial regulation of acute extrafollicular B-cell responses to COVID-19 severity.

Cao T, Liu L, To K, Lim C, Zhou R, Ming Y Clin Transl Med. 2022; 12(9):e1025.

PMID: 36103567 PMC: 9473490. DOI: 10.1002/ctm2.1025.


References
1.
Donnelly C, Fisher M, Fraser C, Ghani A, Riley S, Ferguson N . Epidemiological and genetic analysis of severe acute respiratory syndrome. Lancet Infect Dis. 2004; 4(11):672-83. PMC: 7106498. DOI: 10.1016/S1473-3099(04)01173-9. View

2.
Han D, Penn-Nicholson A, Cho M . Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor. Virology. 2006; 350(1):15-25. PMC: 7111894. DOI: 10.1016/j.virol.2006.01.029. View

3.
Chen Z, Zhang L, Qin C, Ba L, Yi C, Zhang F . Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J Virol. 2005; 79(5):2678-88. PMC: 548443. DOI: 10.1128/JVI.79.5.2678-2688.2005. View

4.
Riley S, Fraser C, Donnelly C, Ghani A, Abu-Raddad L, Hedley A . Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science. 2003; 300(5627):1961-6. DOI: 10.1126/science.1086478. View

5.
Itoyama S, Keicho N, Hijikata M, Quy T, Phi N, Long H . Identification of an alternative 5'-untranslated exon and new polymorphisms of angiotensin-converting enzyme 2 gene: lack of association with SARS in the Vietnamese population. Am J Med Genet A. 2005; 136(1):52-7. PMC: 7138097. DOI: 10.1002/ajmg.a.30779. View